We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$2.76B
AUM Growth
+$132M
Cap. Flow
-$12.2M
Cap. Flow %
-0.44%
Top 10 Hldgs %
16.26%
Holding
440
New
32
Increased
174
Reduced
185
Closed
33

Top Buys

Rank Stock Value
1
CNK icon
Cinemark Holdings
CNK
+$7.16M
2
PPL
PPL Corp
PPL
+$6.93M
3
KDP icon
Keurig Dr Pepper
KDP
+$6.58M
4
ESI icon
Element Solutions
ESI
+$6.21M
5
XOM icon
ExxonMobil
XOM
+$5.88M

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Financials 13.32%
3 Healthcare 13.15%
4 Industrials 12.09%
5 Consumer Discretionary 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN icon
376
Biohaven
BHVN
$2.21B
$587K 0.02%
24,560
+1,187
+5% +$20.4K
IVV icon
377
iShares Core S&P 500 ETF
IVV
$904B
$573K 0.02%
1,286
CBAY
378
DELISTED
Cymabay Therapeutics
CBAY
$537K 0.02%
49,028
+2,373
+5% +$22.1K
HALO icon
379
Halozyme
HALO
$12.2B
$492K 0.02%
13,649
-10,029
-42% -$342K
HCI icon
380
HCI Group
HCI
$2.41B
$486K 0.02%
+7,861
New +$432K
TTI icon
381
TETRA Technologies
TTI
$1.26B
$479K 0.02%
141,748
+6,874
+5% +$19.9K
LEN icon
382
Lennar Class A
LEN
$21.2B
$479K 0.02%
+3,945
New +$431K
ALGN icon
383
Align Technology
ALGN
$12.3B
$471K 0.02%
1,332
-46
-3% -$14.6K
HLIT icon
384
Harmonic Inc
HLIT
$1.28B
$454K 0.02%
28,069
+1,357
+5% +$21.8K
IMVT icon
385
Immunovant
IMVT
$8.25B
$439K 0.02%
23,126
+1,122
+5% +$20.9K
PCVX icon
386
Vaxcyte
PCVX
$8.64B
$419K 0.02%
+8,393
New +$398K
CTLT
387
DELISTED
CATALENT, INC.
CTLT
$409K 0.01%
+9,444
New +$415K
GDYN icon
388
Grid Dynamics Holdings
GDYN
$615M
$385K 0.01%
41,605
+2,015
+5% +$20.2K
PTGX icon
389
Protagonist Therapeutics
PTGX
$9.44B
$380K 0.01%
+13,744
New +$344K
SWKS icon
390
Skyworks Solutions
SWKS
$10.6B
$371K 0.01%
3,350
-118
-3% -$12.4K
DVN icon
391
Devon Energy
DVN
$47.3B
$365K 0.01%
7,544
-270
-3% -$13.6K
SYNA icon
392
Synaptics
SYNA
$4.15B
$345K 0.01%
4,040
+195
+5% +$16.9K
GIS icon
393
General Mills
GIS
$19.7B
$330K 0.01%
4,303
-141
-3% -$12.1K
OMC icon
394
Omnicom Group
OMC
$23.4B
$302K 0.01%
3,176
-497
-14% -$46.1K
INSM icon
395
Insmed
INSM
$28.6B
$288K 0.01%
13,661
+664
+5% +$12.6K
UPS icon
396
United Parcel Service
UPS
$88.9B
$282K 0.01%
1,574
-57
-3% -$10.1K
CVS icon
397
CVS Health
CVS
$122B
$277K 0.01%
4,005
+1,233
+44% +$87.7K
CMCSA icon
398
Comcast
CMCSA
$90B
$274K 0.01%
6,589
-391
-6% -$15.5K
J icon
399
Jacobs Solutions
J
$17B
$268K 0.01%
2,725
-169
-6% -$16.1K
ABR icon
400
Arbor Realty Trust
ABR
$998M
-71,148
Closed -$817K

Similar funds

Chartwell Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Chartwell Investment Partners held 440 positions worth $2.76B, up 5% from $2.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners's Q2 2023 filing shows 32 new, 174 increased, 185 reduced and 33 closed positions. Its largest new stake was Keurig Dr Pepper: 200,604 shares worth $6.27M. The largest sale was NVIDIA, an estimated $11.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Chartwell Investment Partners's largest Q2 2023 buy was Keurig Dr Pepper: 200,604 shares worth $6.27M.
  • Chartwell Investment Partners added most to Cinemark Holdings in Q2 2023, an estimated $7.16M increase.
  • Chartwell Investment Partners's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $11.1M.
  • Chartwell Investment Partners fully exited McGrath RentCorp in Q2 2023, selling an estimated $9.28M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $2.76B portfolio in Q2 2023.
  • Chartwell Investment Partners opened 32 new positions and closed 33 in Q2 2023.
  • Chartwell Investment Partners's portfolio value rose 5% quarter-over-quarter to $2.76B.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.